Download PDF
1 / Pages

Other users also viewed these articles

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study Gustavo H. Pereira; Helena R. Peixoto; Mariana L. Giusti; Mariana L. Souza; Livia B. Victor; Flávia Fernandes; Renata M. Perez; Cristiane A. Villela-Nogueira;
Braz J Infect Dis. 2022;26:
National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents Maria Lúcia Gomes Ferraz; Leonora de Zorzi Piccoli; Rosamar Rezende; Luiz Augusto Borba; Alcindo Pissaia Junior; Hugo Cheinquer; Giovanni Faria Silva; Paulo Roberto Abrão Ferreira; Cristiane Alves Villela-Nogueira; Daniel Ferraz Mazo; Fernanda Fernandes Souza; Liana Codes; Claudia Alexandra Pontes Ivantes; Geisa Perez Medina Gomide; Gustavo Henrique Santos Pereira; Mário Guimarães Pessôa; Alex Vianey Callado França; Arlene dos Santos Pinto; Rosângela Teixeira; Paulo Lisboa Bittencourt;
Braz J Infect Dis. 2022;26:
Hepatitis C virus genotypes and associated risk factors in the state of Pará, Northern Brazil Geison Luiz Costa de Castro; Ednelza da Graça Silva Amoras; Mauro Sérgio Moura de Araújo; Simone Regina Souza da Silva Conde; Antonio Carlos R. Vallinoto;
Braz J Infect Dis. 2020;24:304-9